A Duchenne Muscular Dystrophy Drug Gains Patient Support
Monday, April 25, 2016 - 20:40
in Health & Medicine
The staff of the Food and Drug Administration said a clinical trial for the drug, eteplirsen, was too small, but advocates said the drug prolonged patients’ ability to walk.